Home - Products - Others - Other Targets - (Cyclo(Glu22-Lys26),Leu27)-pTH (1-31) amide (human)

(Cyclo(Glu22-Lys26),Leu27)-pTH (1-31) amide (human)

CAS No. ———

(Cyclo(Glu22-Lys26),Leu27)-pTH (1-31) amide (human)( ——— )

Catalog No. M40355 CAS No. ———

(Cyclo(Glu22-Lys26),Leu27)-pTH (1-31) amide (human)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (Cyclo(Glu22-Lys26),Leu27)-pTH (1-31) amide (human)
  • Note
    Research use only, not for human use.
  • Brief Description
    (Cyclo(Glu22-Lys26),Leu27)-pTH (1-31) amide (human)
  • Description
    (Cyclo(Glu22-Lys26),Leu27)-pTH (1-31) amide (human)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • NorA-IN-1

    NorA-IN-1 is a NorA efflux inhibitor, which can be used to study overcoming multidrug resistance based on microbial efflux transporter proteins.

  • Bacterial Sortase Su...

    Bacterial Substrate III, Abz/DNP TFA is an internally quenched fluorescent peptide substrate. Staphylococcus aureus transpeptidase sortase A (SrtA) reacts with its native substrate Bacterial Sortase Substrate III, Abz/DNP, cleaving it and catalyzing the formation of an amide bond between the carboxyl group of threonine and the amino group of cell-wall crossbridges.

  • 30-Hydroxygambogic a...

    30-Hydroxygambogic acid exhibits significant cytotoxicities against the human leukemia K562/S and the corresponding doxorubicin-resistant K562/R cell lines.